Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

NCT06450886 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Inclusion Body Myositis (IBM)

Interventions

DRUG: Ulviprubart (ABC008)

Sponsor

Abcuro, Inc.